Mark Cochran
Presidente presso IFABRIC CORP.
Patrimonio netto: 137 302 $ in data 31/05/2024
Profilo
Mark A.
Cochran is the founder of Protein Sciences Corp.
(founded in 1983) and NeuroVentures Capital LLC (founded in 2000).
His current jobs include Chairman at iFabric Corp.
(since 2015) and Independent Director at Microbix Biosystems, Inc. (since 1990).
He is also the Chief Operating Officer & Director at Neuro-Innovators LLC and the Executive Director at Johns Hopkins Medicine, Inc.His former jobs include Chairman & Interim Chief Executive Officer at Rivanna Pharmaceuticals, Inc., Chief Executive Officer at Blanchette Rockefeller Neurosciences Institute, Director at Acumen Pharmaceuticals, Inc. and Transgeneron Therapeutics, Inc., Vice President-Business Development at Bayer Pharmaceuticals Corp., Senior Member at Lumira Capital Investment Management, Inc., and MD-Johns Hopkins Healthcare Solutions at Johns Hopkins Health Plans LLC.
Dr. Cochran's education includes a doctorate from Queen's University, a graduate degree from the University of Guelph, and an undergraduate degree from the University of Toronto.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MICROBIX BIOSYSTEMS INC.
0.40% | 23/02/2024 | 549 277 ( 0.40% ) | 127 982 $ | 31/05/2024 |
IFABRIC CORP.
0.03% | 13/05/2024 | 10 000 ( 0.03% ) | 9 320 $ | 31/05/2024 |
Posizioni attive di Mark Cochran
| Società | Posizione | Inizio |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Direttore/Membro del Consiglio | 16/10/2002 |
| IFABRIC CORP. | Presidente | 01/04/2020 |
| Neuro-Innovators LLC | Direttore operativo | - |
Johns Hopkins Medicine, Inc.
 Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Johns Hopkins Medicine, Inc. owns and operates hospitals. It offers health care services in the areas of burn and wound care, cardiac surgery, cardiology, endocrinology, gastroenterology, gynecology/obstetrics, innovation in quality patient care, internal medicine, nephrology, neurology, neurosurgery, oncology, orthopedic surgery, otolaryngology-head and neck surgery. The company was founded by Johns Hopkins in 1997 and is headquartered in Baltimore, MD. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mark Cochran
| Società | Posizione | Fine |
|---|---|---|
NeuroVentures Capital LLC
 NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Fondatore | 31/12/2020 |
Blanchette Rockefeller Neurosciences Institute
 Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Presidente | 14/06/2010 |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
Johns Hopkins HealthCare LLC
 Johns Hopkins HealthCare LLC Packaged SoftwareTechnology Services Johns Hopkins HealthCare LLC provides health care services for four health plans: Priority Partners Managed Care Organization, Johns Hopkins Employer Health Programs (EHP), Johns Hopkins US Family Health Plan (USFHP) and Johns Hopkins Advantage MD (Advantage MD). The company is headquartered in Glen Burnie, MD. | Corporate Officer/Principal | - |
Protein Sciences Corp.
 Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Fondatore | - |
Formazione di Mark Cochran
| University of Guelph | Graduate Degree |
| University of Toronto | Undergraduate Degree |
| Queen's University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| IFABRIC CORP. | Consumer Non-Durables |
| Aziende private | 10 |
|---|---|
NeuroVentures Capital LLC
NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Finance |
Blanchette Rockefeller Neurosciences Institute
Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Blanchette Rockefeller Neurosciences Institute provides health care solutions. The company offers to facilitate molecular signaling, which controls the functions that record our conscience experience. The company is headquartered in Morgantown, WV. | Health Technology |
Transgeneron Therapeutics, Inc.
 Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transgeneron Therapeutics, Inc. researches and develops therapies to treat diseases. It develops therapeutic medicine that promotes tissue regeneration by reprogramming healthy tissue. This therapeutic reprogramming causes cells to 'trans-differentiate' into cells that can replace diseased or degenerated organs. The company was founded in April 2007 and is located in Gainesville, FL | Health Technology |
Rivanna Pharmaceuticals, Inc.
 Rivanna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rivanna Pharmaceuticals, Inc. develops biopharmaceutical products. It engages in the development of molecule therapeutic products which are used for the treatment of neurological diseases and cancer. The company is headquartered in Charlottesville, VA | Health Technology |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Health Technology |
Johns Hopkins HealthCare LLC
Johns Hopkins HealthCare LLC Packaged SoftwareTechnology Services Johns Hopkins HealthCare LLC provides health care services for four health plans: Priority Partners Managed Care Organization, Johns Hopkins Employer Health Programs (EHP), Johns Hopkins US Family Health Plan (USFHP) and Johns Hopkins Advantage MD (Advantage MD). The company is headquartered in Glen Burnie, MD. | Technology Services |
| Bayer Pharmaceuticals Corp. | |
| Neuro-Innovators LLC | |
Johns Hopkins Medicine, Inc.
Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Johns Hopkins Medicine, Inc. owns and operates hospitals. It offers health care services in the areas of burn and wound care, cardiac surgery, cardiology, endocrinology, gastroenterology, gynecology/obstetrics, innovation in quality patient care, internal medicine, nephrology, neurology, neurosurgery, oncology, orthopedic surgery, otolaryngology-head and neck surgery. The company was founded by Johns Hopkins in 1997 and is headquartered in Baltimore, MD. | Health Services |
- Borsa valori
- Insiders
- Mark Cochran
